+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight



Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight



Acta Medica Scandinavica. Supplementum 625: 59-64




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 038953953

Download citation: RISBibTeXText

PMID: 34981

DOI: 10.1111/j.0954-6820.1979.tb00743.x


Related references

The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure heart rate working capacity plasma renin activity plasma angiotensin ii urinary catecholamines and aldosterone in patients with essential hypertension. British Journal of Clinical Pharmacology 21(6): 633-640, 1986

Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension. Clinical Science 57 Suppl 5: 371s-373s, 1979

Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension. European Journal of Clinical Pharmacology 16(5): 305-310, 1979

Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines. Arzneimittel-Forschung 31(3): 524-526, 1981

Relationship between plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure during postural stress in normal subjects. Journal of Laboratory and Clinical Medicine 95(6): 927-933, 1980

The effects of converting enzyme inhibition on exercise induced changes of plasma potassium blood pressure plasma renin activity and plasma aldosterone in essential hypertension. Journal of Endocrinology 108(SUPPL), 1986

Effects of excessive salt-loading on blood pressure, plasma norepinephrine concentration, plasma renin activity, plasma aldosterone concentration and urinary aldosterone excretion in patients with essential hypertension and normotensive subjects. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 72(1): 38-46, 1983

Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertension. Clinical Science and Molecular Medicine. Suppl. 4: 93s-96s, 1978

Relationship of plasma norepinephrine to blood pressure plasma renin activity mineralo corticoids and plasma volume in essential hypertension. Clinical Research 26(3): 556A, 1978

Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension. Transactions of the Association of American Physicians 91: 368-380, 1978

Effect of pinacidil on blood pressure plasma catecholamines and plasma renin activity in essential hypertension. European Journal of Clinical Pharmacology 28(5): 495-500, 1985

Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure. Schweizerische Medizinische Wochenschrift 106(49): 1729-1732, 1976

Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension. Japanese Heart Journal 16(4): 404-420, 1975

Influence of propranolol on plasma-renin activity, plasma-aldosterone concentration and blood pressure in patients with essential hypertension. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1321-1325, 1976

Effects of a converting enzyme inhibitor on blood pressure plasma renin activity and plasma aldosterone in hypertension diabetics compared to patients with essential hypertension. Clinical Research 33(1): 51A, 1985